Disclosures for "Humoral Signatures of MOG-antibody Associated Disease Track with Age and Disease Activity"
-
The institution of Dr. Spatola has received research support from American Academy of Neurology. Dr. Spatola has received research support from Swiss National Funding. The institution of Dr. Spatola has received research support from La Caixa Foundation. The institution of Dr. Spatola has received research support from Spanish National Health Institute.
-
Dr. Chuquisana has nothing to disclose.
-
Dr. Jung has nothing to disclose.
-
Mr. Lopez has nothing to disclose.
-
Eva Maria Wendel has nothing to disclose.
-
Dr. Ramanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Ramanathan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Alexion, Novartis. Dr. Ramanathan has received research support from NHMRC, RACP, University of Sydney.
-
Dr. Keller has nothing to disclose.
-
Prof. Hahn has nothing to disclose.
-
Prof. Meinl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Meinl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Prof. Meinl has received research support from Novartis. The institution of Prof. Meinl has received research support from Merck. The institution of Prof. Meinl has received research support from Roche. The institution of Prof. Meinl has received research support from Glycoera. The institution of Prof. Meinl has received research support from Alexion.
-
The institution of Dr. Reindl has received research support from Euroimmun. The institution of Dr. Reindl has received research support from Roche.
-
Mr. Dale has nothing to disclose.
-
Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NexGen. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Worldwide Clinical Trials. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Toleranzia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
-
Prof. Lauffenburger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied BioMath. Prof. Lauffenburger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immuneering. The institution of an immediate family member of Prof. Lauffenburger has received research support from NovoNordisk.
-
Kevin Rostasy has nothing to disclose.
-
Fabienne Brilot has received personal compensation for serving as an employee of The University of Sydney. Fabienne Brilot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Fabienne Brilot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Fabienne Brilot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck serono. The institution of Fabienne Brilot has received research support from NHRMC. The institution of Fabienne Brilot has received research support from Mukltiple Sclerosis Research Australia.
-
Galit Alter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Galit Alter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Galit Alter has received stock or an ownership interest from SeromYx Systems. Galit Alter has received stock or an ownership interest from Leyden Labs. An immediate family member of Galit Alter has received stock or an ownership interest from Leyden Labs. The institution of Galit Alter has received research support from BioNetch. The institution of Galit Alter has received research support from Sanofi. The institution of Galit Alter has received research support from Medicago. Galit Alter has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Galit Alter has received publishing royalties from a publication relating to health care. Galit Alter has received personal compensation in the range of $10,000-$49,999 for serving as a Senior Director Technology with Leyden Labs.
-
Dr. Lünemann has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ArgenX. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma GmbH. The institution of Dr. Lünemann has received research support from German Research Foundation. The institution of Dr. Lünemann has received research support from French National Research Agency (ANR). The institution of Dr. Lünemann has received research support from National Multiple Sclerosis Society (NMSS). The institution of Dr. Lünemann has received research support from National Institute of Health.